Concepedia

Publication | Open Access

Stopping Mesalamine Therapy in Patients With Crohn’s Disease Starting Biologic Therapy Does Not Increase Risk of Adverse Outcomes

DOIFull Paper Access

31

Citations

14

References

2019

Year

Ryan C. Ungaro, Berkeley N. Limketkai, Camilla Bjørn Jensen, Clara Yzet, Kristine H. Allin, Manasi Agrawal, Thomas Ullman, Johan Burisch, Tine Jess, Jean‐Frédéric Colombel
Clinical Gastroenterology and Hepatology

References

YearCitations

Page 1